chrisvoncsefalvay/vaers-outcomes huggingface dataset:
in the same arm that he got the shot under his armpit its swollen; This is a spontaneous report received from a contactable consumer. This consumer (patient's wife) reported for a patient (reporter's husband) that:  A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization and not ongoing. On an unspecified date the patient experienced his armpit its swollen. The reporter stated that the patient got the shot on Monday the second one in the same arm that he got the shot under his armpit its swollen and today is Thursday. The outcome of the event was unknown. No follow attempts are needed; information about lot/batch number cannot be obtained
Intense nausea and vomiting, weakness, headache, fever, and chills.
DTaP received at 11:00AM on 10/21/02. Patient developed staring spells and jerking movements later in the evening 10/21/02. Three episodes total as of 10/22/02 at 11:00AM. Patient was afebrile.
Expired 3/12/2022, hospitalized 2/16-3/12.
Patient received Pfizer and was scheduled and due to receive second dose of moderna. No adverse reactions at this time.
Pain; Torticollis spastic; This is a spontaneous report from a contactable physician. This physician reported similar events for five patients. This is the third of five reports.   A 17-year-old male patient received meningococcal group b rlp2086 (TRUMENBA lot number: AT1920) intramuscular on the left arm on 28Aug2020 11:28 at a single dose (reported as 1-1-1/2) for Men B/immunization; meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA lot number: U6575AA) intramuscular on the right arm on 28Aug2020 at an unspecified dose for immunisation and hepatitis a vaccine (lot number: 7595K) intramuscular on the right arm on 28Aug2020 at an unspecified dose for immunisation. The patient had no medical history, concomitant medications and relevant test. On 30Aug2020 the patient experienced torticollis spastic. Patient still gets tingling with movement of neck. On an unspecified date, the patient experienced pain. The patient was not hospitalized due to the events. The events required a visit to the physician office. Patient was given Lorlatinib as treatment. Patient getting P.T. Outcome of the event Torticollis spastic was not recovered while unknown for the other event. It was reported that there was a reasonable possibility that the events were related to the suspect product.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020343033 Same reporter, similar drugs and events, different patient
swollen face; swollen tongue; swollen arms; fast heart beat; This is a spontaneous report from a Pfizer sponsored program COVAX US Support contactable consumer (Patient).   A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and Expiry date was not reported), via an unspecified route of administration on 26Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. The patient she got the 1st dose of the vaccine on 26Feb2021and she experienced on unspecified date severe side effects and allergies like swollen face, tongue and arms and fast heart beat after taking the 1st dose. She's not yet done with the second dose and she wants to know if she needs to take it after having the side effects from the 1st dose. She also asked if she will have the same side effects for the 2nd dose. The outcome for the events swollen face, tongue and arms and fast heart beat was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a consumer via call center representative and described the occurrence of local swelling in a 82-year-old male patient who received SHINGRIX for prophylaxis. On 19th November 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, 7 days after receiving SHINGRIX, the patient experienced local swelling, red rash and adverse reaction. On an unknown date, the outcome of the local swelling and red rash were recovered/resolved and the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the local swelling, red rash and adverse reaction to be related to SHINGRIX. Additional details were provided as follows: The patient received 1st shot of SHINGRIX series intramuscularly in the left deltoid but had a reaction. A week later, he got a knot on the right inside of shin lower leg about half the size of a tennis ball. Knot stayed for 3 days then it went away. About a week later it turned into a red rash on inside of the same leg from knee to ankle, both of these events resolved completely. 1 to 2 weeks later, he developed a knot on the outer side of the same leg. He had an ultrasound done which ruled out a blood clot. This outer knot was mostly resolved because if you rub real hard you feel something on the outside right leg. Lab Comments: On unknown date the ultrasound ruled out a blood clot.
numbness of the left heel within two days of the shot; This is a spontaneous report from a contactable consumer (patient).   A 67-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 21Mar2021 08:45 (Batch/Lot Number: EP7534), at the age of 67-years at vaccination, as SINGLE DOSE for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The patient received dose 1 of the vaccine on Feb2021 on left arm (lot number: EN6202). It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. On 23Mar2021 10:00, the patient experienced numbness of the left heel within two days of the shot (disability).  The patient underwent lab tests and procedures which included blood work: unknown result on 26Mar2021.  The outcome of the evet was not recovered. Therapeutic measures were taken as a result of the event. Since the vaccination, the patient has not been tested for COVID-19.
immed p/vax pt broke out in generalized rash; no difficulty breathing etc; MD notified; MD did not want to see pt but instructed mom to get pt DPH;
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 22-OCT-2018, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R000554 with expiration date 08-JAN-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010371: US-009507513-1907USA010372: US-009507513-1907USA010373:
Day after shot, got itchy macules consistent clinically with atopic dermatitis at the L lateral and anterior neck extending onto upper L anterior chest and upper L trapezius.  Not at the site of injection. Had some nausea.  then 10/25 developed R sided mid thoracic back pain which over the next 8 days radiated to the R lateral chest and then anterior chest.  constant ache.  red rash developed over the next few days.  The R sided symptoms are clinically consistent with zoster/shinges.
Urticaria without respiratory distress within 8 hours of Fluzone vaccine.  Persisted for days. Widespread giant urticaria without joint symptoms.
15 minutes after patient received vaccine, pt complaints of itching to scalp area, lower legs, lower back, complaints of redness; notified staff at 6:30 pm (20 minutes after itching started) no hives seen, no breathing difficulty or swelling to tongue;  6:36 pm Benadryl 50 mg PO given to patient, history of allergies discussed,  lungs clear, BP 120/90, HR 100, O2 sat 99%; no development of hives, itching began to subside after 15-20 minutes, no redness seen 7:00 pm BP 144/98, HR 87, pt states she feels better, has a ride home with significant other, informed patient to call allergist, pt aware to call 911 or go to nearest ER if has difficulty breathing, hives or itchy/swelling to throat, pt verbalized understanding and left site accompanied by significant other who would be driving, RN On 03/12/2021, left message for patient to call if she has any further symptoms ,RN
Information has been received from a physician concerning a 63 year old female pt who on 2/13/02 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. On 2/18/02, the pt developed a swollen arm. Unspecified medical attention was sought. Additional info has been requested.
Information has been received on 22 MAY 2002 from a father concerning his 5 year old daughter who at 18 months of age was vaccinated approximately 1999 with a dose of MMR virus vaccine live. The child was diagnosed with autism a short time after vaccination. The patient sought unspecified medical attention. Upon internal review autism was considered to be an other important medical event. Additional information has been requested.
Weird taste/metallic taste in mouth; Fever Less than 100; Chills/Bodyaches; Chills/Bodyaches; This is a spontaneous report received from a contactable consumer (Patient) via in response the Non HCP letter sent in cross referenced case. A 51-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration at left arm (at the age of 51-year-old) on 23Jan2021 (Lot Number: EL9262) as single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included ibuprofen (ADVIL). No there are not any other products that were taken together with those Indicated above. Patient did not receive any other vaccine prior to this vaccination within 4weeks. Patient did not have any adverse events prior to the vaccination. There were no predisposing factors. The patient did not visit emergency room/ Physician office for the events. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration at left arm (at the age of 50-year-old) on 02Jan2021 11:30 (Lot Number: EK9231) as single dose for COVID-19 immunisation and patient experienced 30 minutes after vaccine had a really weird taste in mouth for about 2 hours, throwingup/vomiting, fever more than 100, chills, bodyaches, mettalic taste in mouth. After second dose the patient experienced Same symptoms after 2 dose except vomiting i.e weird taste, fever less than 100 and chills/bodyaches on an unspecified date in 2021. The patient underwent lab tests and procedures which included body temperature: less than 100 on an unspecified date in 2021. Outcome of all events was unknown.  Follow-up attempts completed. No further information expected.
She explained that she has taken the original vaccine (primary series) and two booster doses of the Pfizer-BioNTech COVID-19 Vaccine and that every dose made her very sick; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team. The reporter is the patient.  A 70-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 Immunization, reaction(s): "sick"; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 Immunization, reaction(s): "sick". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "She explained that she has taken the original vaccine (primary series) and two booster doses of the Pfizer-BioNTech COVID-19 Vaccine and that every dose made her very sick".  Additional information: Transferring agent stated, "She was an Optometrist, described that she had taken four doses of the Pfizer COVID-19 Vaccine and the original primary series and two booster doses and described that the vaccines (COVID-19 Vaccine) make her very sick both the primary and the booster doses. She also mentioned that she took a third booster dose from Moderna (Unspecified Vaccine) and that vaccine didn't make her sick at all. Patient was trying to find a Moderna Bivalent booster to take and did found where they are.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201206645 Same patient/drug/event, different dose;US-PFIZER INC-202201210015 Same patient/drug/event, different dose;
Vaccine provided at 4:35pm. Patient was asked to wait 30 minutes observation time due to history of allergies, facial swelling/throat tightness in the past. At 30 minutes she stated she had some numbness in her hand that had gone away, but her heart was racing still and a little bit of throat issues. She waited in the pharmacy longer and intermittently checked on her. She took her heart rate at one point and it was 127. Asked around 1 hour wait time if she wanted to inform her doctor of her symptoms and any next steps. Around 5:50pm the patient reported she was having trouble breathing so 911 was called and an epinephrine pen was administered. The paramedics came shortly after and took the patient to hospital where she stayed around 4 hours.
I had my second shot and the same night developed a clot in my arm. I had blood coagulation labs drawn and my C protein and cardiolipin have altered and show I may get clots now. I had labs previous to this because of my gallbladder surgery and all my blood was normal.
sore throat; did become positive for COVID19; body aches; fever; severe arm pain; A spontaneous report was received from a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced severe arm pain, body aches, fever, sore throat and became positive for COVID-19.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 30 Dec 2020, the patient received the first of two planned doses of mRNA-1273 intramuscularly for COVID-19 for infection prophylaxis.  On 30 Dec 2020 in the evening, the patient reported that she had severe arm pain, body aches, fever and a sore throat. At the time of report, she stated that she still had the symptoms and that they had worsened.  On an unknown date, the patient tested positive for COVID-19. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, severe arm pain, body aches, fever and sore throat, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the event of Covid-19 positive, is Unlikely related to mRNA-1273 and a very limited information regarding this event has been provided.  Further information has been requested
Skin rashes, joint pain, muscle aches and pain, fatigue, vision problems, memory problems. Time course: October 1998 to present. Treatment: Prescription medications. Currently, under doctor's care. Treatment is still going on. Follow-up information recieved 07/20/00, indicates that pt's events are ongoing and unresolve. These include severe joint/leg pain, muscle aches, skin rashes, fatigue, short term memory loss, and vision problems. Has received dx of Reflex Sympathetic Dystrophy syndrome from a pain management specialist.
my arm was changing colors; my arm swelled up pretty bad; my arm was really painful; A spontaneous report was received from a healthcare professional concerning a 70-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events my arm swelled up pretty bad, my arm was really painful, my arm was changing colors.  The patient's medical history was not provided. Concomitant medications reported were gabapentin 100 mg tabs 1 tab PO QHS for drug use for unknown indication.  On 26 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 002A21A) intramuscularly for prophylaxis of COVID-19 infection.  On 26 Feb 2021, the patient experienced the event(s) my arm swelled up pretty bad. my arm was really painful. On 27 Feb 2021, the patient experienced the event(s) my arm was changing colors.  Treatment details included None..  Action taken with mRNA-1273 in response to the events were  not reported.  The outcome of event, my arm swelled up pretty bad was considered resolved on 2 Mar 2021.The outcome of events, my arm was really painful was considered resolved on 2 Mar 2021.The outcome of event, my arm was changing colors was considered resolved on 2 Mar 2021.  was unknown.
20 minutes after the injection, the patient's first ever flu shot, she developed generalised erythema rash, facial sweeling and shortness of breath. This flu shot was done at a school site. Volunteer doctors (unspecified) and was attended by ER physician. She was given oral prednisolone for 4 days and albuterol inhalation at ER. 5 days after this episode in my clinic, she is well and normal peak flow.
This case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a 76-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms and myalgia. On an unknown date, the outcome of the influenza-like symptoms and myalgia were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms and myalgia to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a nurse practitioner. The nurse practitioner reported that the patient experienced significant myalgias and developed severe flu like symptoms within 12 hours of receiving SHINGRIX. The reporter stated that the patient stated that it was an awful experience and lasted upwards of an entire week. The nurse practitioner did not feel like the patient would be willing to receive the second dose of the SHINGRIX vaccine. The nurse practitioner stated that she would be unable to provide any more specifics since she could not recall the patient name to identify them in their medical records. This case was linked with US2018GSK082079 and US2018GSK082075, reported by the same reporter.
This spontaneous report as received from a pharmacist via a company representative refers to 4-5 patients seen in hospital obgyn (obstetrician/gynecologist) clinic who were of unknown age and gender. On an unknown date, the patients were vaccinated with a dose of PNEUMOVAX 23 (lot number, expiry date and route were not reported) 0.5 milliliter (ml) (reported as standard dose) in the leg. On an unknown date, the patients developed swelling and phlebitis. One of the patient had a reaction severe enough to seek attention in emergency room. It was unknown if the other patients sought medical attention or recovered treatment. The outcome of phlebitis and swelling was unknown. Additional information has been requested.
Pt recvd 2nd dose Hep B 26AUG87 & MD stated vax was Engerix-B & 1 mo p/vax devel fatigue, splenomegaly & elevated liver function tests; sx were described as chronic fatigue synd; MD felt pts chronic fatigue synd was assoc w/immun  problem;
shingles; rash on her ribs on her front right side; pulled muscle; pain in her right back shoulder blade; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), PAIN (pain in her right back shoulder blade), RASH (rash on her ribs on her front right side) and MUSCLE STRAIN (pulled muscle) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PAIN (pain in her right back shoulder blade) and MUSCLE STRAIN (pulled muscle). On 21-Feb-2021, the patient experienced RASH (rash on her ribs on her front right side). On 22-Feb-2021, the patient experienced HERPES ZOSTER (shingles). On 22-Feb-2021, MUSCLE STRAIN (pulled muscle) had resolved. At the time of the report, HERPES ZOSTER (shingles), PAIN (pain in her right back shoulder blade) and RASH (rash on her ribs on her front right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
My baby girl SCREAMED her lil head off for well over and hour in a half..she was inconsolable..She  also appears to be choking on her saliva .Like she is inhaling it or something. Didn't take a bottle or breast..Alsoher cry sounds completely diffrent.Almost like it's a comoletly diffrent child..I can't sleep because I'm so afraid my lil girl will choke on her saliva and drowned.. Or possibly stop breathing